Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Laquinimod for multiple sclerosis.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
Multiple sclerosis.
Arzerra receives approval in Japan
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.

Pages